State Street Corp Crispr Therapeutics Ag Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, State Street Corp holds 2,992,988 shares of CRSP stock, worth $120 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,992,988

Previous 2,393,684 25.04%

Holding current value

$120 Million

Previous $129 Million 8.79%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$44.62 - $62.75 $26.7 Million - $37.6 Million	599,304 Added 25.04%	2,992,988 $141 Million
Q2 2024 Aug 14, 2024	BUY	$51.17 - $68.18 $46 Million - $61.3 Million	898,476 Added 60.09%	2,393,684 $129 Million
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $15.7 Million - $23 Million	-258,289 Reduced 14.73%	1,495,208 $102 Million
Q4 2023 Feb 14, 2024	SELL	$38.62 - $72.18 $5.08 Million - $9.49 Million	-131,476 Reduced 6.97%	1,753,497 $110 Million
Q3 2023 Nov 14, 2023	BUY	$45.39 - $59.0 $11.5 Million - $14.9 Million	252,500 Added 15.47%	1,884,973 $85.6 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $15.4 Million - $24 Million	-353,714 Reduced 17.81%	1,632,473 $91.6 Million
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $3.89 Million - $5.33 Million	-94,929 Reduced 4.56%	1,986,187 $89.8 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $20.1 Million - $33.7 Million	512,732 Added 32.69%	2,081,116 $84.6 Million
Q3 2022 Nov 15, 2022	SELL	$61.1 - $83.78 $90,183 - $123,659	-1,476 Reduced 0.09%	1,568,384 $102 Million
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $47.2 Million - $80.7 Million	1,092,384 Added 228.78%	1,569,860 $95.4 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $14.4 Million - $21.4 Million	269,824 Added 129.94%	477,476 $30 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $3.15 Million - $5.01 Million	45,010 Added 27.67%	207,652 $15.7 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $1.29 Million - $1.84 Million	11,726 Added 7.77%	162,642 $18.2 Million
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $167,495 - $268,899	1,661 Added 1.11%	150,916 $24.4 Million
Q1 2021 Jul 09, 2021	BUY	$110.72 - $210.04 $782,347 - $1.48 Million	7,066 Added 4.97%	149,255 $18.2 Million
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $755,996 - $1.43 Million	6,828 Added 5.04%	142,189 $17.3 Million
Q4 2020 Feb 16, 2021	SELL	$79.67 - $173.23 $474,036 - $1.03 Million	-5,950 Reduced 4.21%	135,361 $20.7 Million
Q3 2020 Nov 10, 2020	BUY	$78.5 - $100.64 $1.61 Million - $2.07 Million	20,522 Added 16.99%	141,311 $11.8 Million
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $1.91 Million - $3.77 Million	49,578 Added 69.62%	120,789 $8.88 Million
Q1 2020 May 11, 2020	BUY	$33.68 - $62.53 $2.4 Million - $4.45 Million	71,211 New	71,211 $3.02 Million

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.12B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Crispr Therapeutics Ag Transaction History